NO20012563D0 - Anvendelse av benzoylguanidiner til behandling av ikke- insulinavhengig diabetes mellitus - Google Patents

Anvendelse av benzoylguanidiner til behandling av ikke- insulinavhengig diabetes mellitus

Info

Publication number
NO20012563D0
NO20012563D0 NO20012563A NO20012563A NO20012563D0 NO 20012563 D0 NO20012563 D0 NO 20012563D0 NO 20012563 A NO20012563 A NO 20012563A NO 20012563 A NO20012563 A NO 20012563A NO 20012563 D0 NO20012563 D0 NO 20012563D0
Authority
NO
Norway
Prior art keywords
benzoylguanidines
insulin
treatment
diabetes mellitus
dependent diabetes
Prior art date
Application number
NO20012563A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012563L (no
Inventor
Rolf Gericke
Manfred Baumgarth
Klaus-Otto Minck
Didier Mesangeau
Liliane Doare
Micheline Kergoat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20012563L publication Critical patent/NO20012563L/no
Publication of NO20012563D0 publication Critical patent/NO20012563D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
NO20012563A 1998-11-26 2001-05-25 Anvendelse av benzoylguanidiner til behandling av ikke- insulinavhengig diabetes mellitus NO20012563D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98122419 1998-11-26
PCT/EP1999/008795 WO2000030624A2 (fr) 1998-11-26 1999-11-16 Utilisation de benzoylguanidines pour le traitement du diabete non insulino-dependant

Publications (2)

Publication Number Publication Date
NO20012563L NO20012563L (no) 2001-05-25
NO20012563D0 true NO20012563D0 (no) 2001-05-25

Family

ID=8233036

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012563A NO20012563D0 (no) 1998-11-26 2001-05-25 Anvendelse av benzoylguanidiner til behandling av ikke- insulinavhengig diabetes mellitus

Country Status (14)

Country Link
EP (1) EP1131064A2 (fr)
JP (1) JP2002530325A (fr)
KR (1) KR20010080597A (fr)
CN (1) CN1328452A (fr)
AR (1) AR023064A1 (fr)
AU (1) AU1553500A (fr)
BR (1) BR9915667A (fr)
CA (1) CA2352154A1 (fr)
CZ (1) CZ20011785A3 (fr)
HU (1) HUP0104418A2 (fr)
ID (1) ID29523A (fr)
NO (1) NO20012563D0 (fr)
PL (1) PL348152A1 (fr)
WO (1) WO2000030624A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2488342A1 (fr) * 2002-06-05 2003-12-18 Institute Of Medicinal Molecular Design, Inc. Medicaments therapeutiques destines au diabete
US7381841B2 (en) 2003-08-22 2008-06-03 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
DE102004054847A1 (de) * 2004-11-13 2006-05-24 Sanofi-Aventis Deutschland Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430916A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE4437874A1 (de) * 1994-10-22 1996-04-25 Merck Patent Gmbh Alkyl-5-methylsulfonyl-benzoylguanidin-Derivate
DE19502644A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh 4-Amino-benzoylguanidin-Derivate
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DE19517848A1 (de) * 1995-05-16 1996-11-21 Merck Patent Gmbh Fluorhaltige Benzoylguanidine
DE19531138A1 (de) * 1995-08-24 1997-02-27 Merck Patent Gmbh Alkenyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
BR9915667A (pt) 2001-08-14
PL348152A1 (en) 2002-05-06
AU1553500A (en) 2000-06-13
ID29523A (id) 2001-09-06
CZ20011785A3 (cs) 2001-10-17
JP2002530325A (ja) 2002-09-17
NO20012563L (no) 2001-05-25
WO2000030624A2 (fr) 2000-06-02
KR20010080597A (ko) 2001-08-22
CA2352154A1 (fr) 2000-06-02
CN1328452A (zh) 2001-12-26
WO2000030624A3 (fr) 2000-10-05
AR023064A1 (es) 2002-09-04
HUP0104418A2 (hu) 2002-04-29
EP1131064A2 (fr) 2001-09-12

Similar Documents

Publication Publication Date Title
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
DK0994865T3 (da) Triazolforbindelser og anvendelsen deraf som dopamin-D3-ligander
NO964548D0 (no) Substituerte sulfonamider som selektive 3 agonister for behandling av diabetes og fedme
NO20022087L (no) Fremgangsmåte for behandling av diabetes
IS6303A (is) Notkun retígabíns til meðhöndlunar á taugasjúkdómatengdum sársauka
NO20020764D0 (no) Benzoesyrederivater for behandling av diabetes mellitus
ID16493A (id) Perlakuan bahan yang mengandung padatan yang diambil dari efluen
DE69906008T2 (de) Blutdruckmessgerät
TR199501454A2 (tr) Su muamele kartusu icin tükenmeyi gösteren mekanizma.
IS2793B (is) Notkun á 3-hýdroxý-3-metýlglútarýl hjálparensíms A afsýringarkljúfshindrum til framleiðslunnar á lyfi til að meðhöndla sykursýkitaugakvilla
ZA99527B (en) Pressure sensitive adhesive matrix patch for the treatment of onychomycosis.
DE122010000029I1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
PT1235831E (pt) Novos compostos de oxabispidina uteis no tratamento de arritmias cardiacas
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
DE69700515D1 (de) Flüssige Silikonkautschukmischung
DE69836697D1 (de) Neue 3,6-Hemiketale der 9a-Azalidklasse
IL133136A0 (en) Use of leptin antagonists for the treatment of diabetes
TR199501206A2 (tr) Sivi antiasit bilesikler
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
PT102054A (pt) Composicao para o tratamento de sementes de arroz
ID21424A (id) Konfigurasi katup gabungan untuk unit siklus-uap
NO20012563D0 (no) Anvendelse av benzoylguanidiner til behandling av ikke- insulinavhengig diabetes mellitus
NO994612D0 (no) Retinoid-relaterte molekyler for behandling av ikke-insulinavhengig diabetes mellitus
PT1069885E (pt) Solucao oftalmica que compreende glicogenio
ID23784A (id) Proses pembuatan turunan alkoksifuranonamina, senyawa-senyawa yang diperoleh melalui proses ini, dan penggunaan senyawa-senyawa ini.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application